SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001839882-24-003361
Filing Date
2024-02-05
Accepted
2024-02-05 09:00:57
Documents
17
Period of Report
2024-02-02
Items
Item 1.03: Bankruptcy or Receivership
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT dmk-8k_020524.htm   iXBRL 8-K 35545
2 PRESS RELEASE ex99-1.htm EX-99.1 14193
6 GRAPHIC dmk-001.jpg GRAPHIC 5788
7 GRAPHIC dmk-002.jpg GRAPHIC 2770
  Complete submission text file 0001839882-24-003361.txt   243578

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dmk-20240205.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dmk-20240205_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dmk-20240205_pre.xml EX-101.PRE 22360
18 EXTRACTED XBRL INSTANCE DOCUMENT dmk-8k_020524_htm.xml XML 3595
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
DMK PHARMACEUTICALS Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 24594191
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)